From: Hemoglobin concentration is associated with the incidence of metabolic syndrome
MetS | Q1 (< 130 g/L) | Q2 (130-136g/L) | Q3 (137-142g/L) | Q4 (≥143 g/L) |
---|---|---|---|---|
n = 716 | n = 654 | n = 703 | n = 719 | |
Incidence, n (%) | 242 (33.8) | 218 (33.3) | 281 (40.0) | 304 (42.3) |
Model 1 | 1 (Ref) | 0.98 (0.78–1.23) | 1.30 (1.05–1.62) * | 1.44 (1.15–1.78) * |
Model 2 | 1 (Ref) | 0.93 (0.74–1.18) | 1.32 (1.05–1.66) * | 1.47 (1.17–1.84) * |
Model 3†| 1 (Ref) | 0.88 (0.67–1.18) | 1.24 (0.95–1.62) | 1.09 (0.83–1.44) |
WC | Q1 (< 131 g/L) | Q2 (131-136g/L) | Q3 (137-142g/L) | Q4 (≥143 g/L) |
n = 499 | n = 456 | n = 453 | n = 483 | |
Incidence, n (%) | 238 (47.7) | 203 (44.5) | 242 (53.4) | 246 (50.9) |
Model 1 | 1 (Ref) | 0.88 (0.68–1.14) | 1.26 (0.98–1.62) | 1.14 (0.89–1.46) |
Model 2 | 1 (Ref) | 0.90 (0.67–1.17) | 1.24 (0.95–1.61) | 1.13 (0.87–1.48) |
Model 3‡ | 1 (Ref) | 0.92 (0.70–1.22) | 1.17 (0.88–1.56) | 1.02 (0.76–1.37) |
BP | Q1 (< 130 g/L) | Q2 (130-136g/L) | Q3 (137-142g/L) | Q4 (≥143 g/L) |
n = 509 | n = 572 | n = 522 | n = 512 | |
Incidence, n (%) | 216 (42.4) | 224 (39.2) | 247 (47.3) | 224 (43.8) |
Model 1 | 1 (Ref) | 0.87 (0.69–1.11) | 1.22 (0.95–1.56) | 1.06 (0.83–1.35) |
Model 2 | 1 (Ref) | 0.81 (0.63–1.05) | 1.19 (0.92–1.54) | 1.00 (0.77–1.30) |
Model 3§ | 1 (Ref) | 0.81 (0.61–1.06) | 1.20 (0.91–1.59) | 0.95 (0.71–1.27) |
TGs | Q1 (< 131 g/L) | Q2 (131-137g/L) | Q3 (138-143g/L) | Q4 (≥144 g/L) |
n = 835 | n = 946 | n = 815 | n = 847 | |
Incidence, n (%) | 142 (17.0) | 201 (21.2) | 193 (23.7) | 205 (24.2) |
Model 1 | 1 (Ref) | 1.32 (1.04–1.67) * | 1.51 (1.19–1.93) * | 1.56 (1.23–1.98) * |
Model 2 | 1 (Ref) | 1.23 (0.96–1.58) | 1.49 (1.16–1.91) * | 1.47 (1.15–1.89) * |
Model 3¶ | 1 (Ref) | 1.11 (0.84–1.45) | 1.36 (1.02–1.80) * | 1.05 (0.79–1.41) |
HDL-c | Q1 (< 132 g/L) | Q2 (132-138g/L) | Q3 (139-144g/L) | Q4 (≥145 g/L) |
n = 566 | n = 612 | n = 537 | n = 556 | |
Incidence, n (%) | 114 (20.1) | 141 (23) | 132 (24.6) | 147 (26.4) |
Model 1 | 1 (Ref) | 1.19 (0.90–1.57) | 1.29 (0.97–1.72) | 1.43 (1.08–1.88) * |
Model 2 | 1 (Ref) | 1.17 (0.88–1.56) | 1.27 (0.95–1.70) | 1.46 (1.09–1.93) * |
Model 3††| 1 (Ref) | 1.06 (0.78–1.43) | 1.10 (0.80–1.50) | 1.14 (0.83–1.57) |
FBG | Q1 (< 131 g/L) | Q2 (131-136g/L) | Q3 (137-142g/L) | Q4 (≥143 g/L) |
n = 455 | n = 434 | n = 449 | n = 437 | |
Incidence, n (%) | 118 (25.9) | 106 (24.4) | 117 (26.1) | 118 (27.0) |
Model 1 | 1 (Ref) | 0.92 (0.68–1.25) | 1.01 (0.75–1.36) | 1.06 (0.79–1.42) |
Model 2 | 1 (Ref) | 0.91 (0.66–1.25) | 1.06 (0.78–1.44) | 1.06 (0.78–1.46) |
Model 3‡‡ | 1 (Ref) | 0.95 (0.66–1.35) | 1.00 (0.69–1.43) | 0.94 (0.64–1.38) |